VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Sunday, January 11, 2026
Stock Comparison
Sanofi vs SS&C Technologies Holdings, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Sanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
SS&C Technologies Holdings, Inc.
SSNC · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into SS&C Technologies Holdings, Inc.'s moat claims, evidence, and risks.
View SSNC analysisComparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 68 / 100 for SS&C Technologies Holdings, Inc.).
- Segment focus: Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)); SS&C Technologies Holdings, Inc. has 3 segments (82.3% in Software-enabled services).
- Moat breadth: Sanofi has 5 moat types across 3 domains; SS&C Technologies Holdings, Inc. has 7 across 4.
Primary market context
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
SS&C Technologies Holdings, Inc.
Software-enabled services
Software-enabled outsourcing and subscription services for financial services and healthcare (fund administration, transfer agency, middle/back office BPO, managed IT)
Global
Financial services firms (asset/wealth managers, alternative managers, banks, insurers) and healthcare payers/administrators
Service provider / outsourcer (SaaS + BPO)
82.3%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Sanofi strengths
SS&C Technologies Holdings, Inc. strengths
Segment mix
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
SS&C Technologies Holdings, Inc. segments
Full profile >Software-enabled services
Oligopoly
License, maintenance and related
Oligopoly
Funds network connectivity (Calastone)
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.